SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Human & Experimental Toxicology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Harvey, P.
Right arrow Articles by Cockburn, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Harvey, P.
Right arrow Articles by Cockburn, A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Glucocorticoid amelioration of nephrotoxicity: a study of cephaloridine- methylprednisolone interaction in the rat

PW Harvey

AgrEvo UK Limited, Toxicology, Chesterford Park, Saffron Walden, Essex CB10 1XL, UK

G. Healing

AgrEvo UK Limited, Toxicology, Chesterford Park, Saffron Walden, Essex CB10 1XL, UK

IR Major

AgrEvo UK Limited, Toxicology, Chesterford Park, Saffron Walden, Essex CB10 1XL, UK

M. McFarlane

AgrEvo UK Limited, Toxicology, Chesterford Park, Saffron Walden, Essex CB10 1XL, UK

KA Purdy

AgrEvo UK Limited, Toxicology, Chesterford Park, Saffron Walden, Essex CB10 1XL, UK

O. Olatunde

AgrEvo UK Limited, Toxicology, Chesterford Park, Saffron Walden, Essex CB10 1XL, UK

MT Garcia Conesa

AgrEvo UK Limited, Toxicology, Chesterford Park, Saffron Walden, Essex CB10 1XL, UK

DJ Everett

AgrEvo UK Limited, Toxicology, Chesterford Park, Saffron Walden, Essex CB10 1XL, UK

A. Cockburn

AgrEvo UK Limited, Toxicology, Chesterford Park, Saffron Walden, Essex CB10 1XL, UK

Groups of ten male rats were treated with a high challenge dose of cephaloridine (CPH, 3750 mg kg -1), with methyl prednisolone (MP, 100 mg kg-1) or with cephaloridine and methylprednisolone (CPH + MP) by single subcutaneous injection. A control group received the injection vehicles only. Urine was collected from all animals daily over 18-h collection periods, up to 96 h after treatment. Blood was collected at 24, 48, 72 and 96 h after treatment. At necrop sy, kidneys were weighed, processed and examined histopathologically.

Results show that methylprednisolone significantly ameliorated the nephrotoxicity of the challenge dose of cephaloridine. CPH-only treated rats had severe toxic nephrosis characterised by acute tubular necrosis, and elevated blood urea and creatinine. By contrast, the major ity of CPH + MP treated rats had only a slight or moderate toxic nephrosis, and had lower blood urea and creatinine levels compared with rats treated with CPH only, indicat ing preservation of kidney function. Interestingly, rats treated with CPH + MP had higher urinary enzymes (alka line phosphatase, lactate dehydrogenase, gamma glu tamyltransferase and N-acetyl-B-glucosaminidase) as well as protein and glucose, compared with rats treated with CPH only. This is taken to indicate that rats treated with CPH only had such marked kidney damage and necrosis that the population of cells able to produce these marker enzymes was significantly and rapidly depleted, but the protection afforded by methylprednisolone allowed CPH + MP treated rats to sustain urinary enzyme output. Effects on urinary glucose and other parameters such as body weight and kidney weight demonstrate interactions between glucocorticoid pharmacology and cephaloridine nephrotoxicity. Finally, the significance of these findings is discussed in terms of a generic mechanism of protection conferred by glucocorticoids in certain types of nephrotox icity and related to similar findings in rats treated intra venously with cisplatin, an anti-neoplastic agent for which the clinical utility in man is often limited by adverse effects on the kidney.

Key Words: cephaloridine • methylprednisolone • kidney • nephrotoxicity • cytoprotection

Human & Experimental Toxicology, Vol. 14, No. 7, 554-561 (1995)
DOI: 10.1177/096032719501400702


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Toxicol PatholHome page
W. F. Loeb
The Measurement of Renal Injury
Toxicol Pathol, January 1, 1998; 26(1): 26 - 28.
[Abstract] [PDF]



Advertisement